Nomura Holdings’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,912,498
Closed -$19.2M 1500
2022
Q4
$19.2M Hold
1,912,498
0.08% 189
2022
Q3
$18.8M Hold
1,912,498
0.08% 199
2022
Q2
$18.7M Hold
1,912,498
0.06% 191
2022
Q1
$18.7M Hold
1,912,498
0.06% 202
2021
Q4
$18.6M Hold
1,912,498
0.05% 288
2021
Q3
$18.6M Hold
1,912,498
0.05% 238
2021
Q2
$18.5M Buy
+1,912,498
New +$18.6M 0.05% 228

Other funds holding COCH

Nomura Holdings's COCH Position: Q1 2023 in Review

Nomura Holdings sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 1,912,498 shares — an estimated $19.2M sold.

Nomura Holdings first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $19.2M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Nomura Holdings reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 1,912,498 Envoy Medical shares in Q1 2023, an estimated $19.2M.
  • Nomura Holdings first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Nomura Holdings's Envoy Medical position peaked at $19.2M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.